B.Riley FBR analyst Marc Wiesenberger reiterated a Buy rating on MTBC (NASDAQ:MTBC) Inc on Monday, setting a price target of $8, which is approximately 25.20% above the present share price of $6.39.
Wiesenberger expects MTBC Inc to post earnings per share (EPS) of -$0.12 for the second quarter of 2020.
The current consensus among 2 TipRanks analysts is for a Moderate Buy rating of shares in MTBC, with an average price target of $7.
The analysts price targets range from a high of $8 to a low of $6.
In its latest earnings report, released on 12/31/2019, the company reported a quarterly revenue of $15.76 million and a net profit of $946.36 thousand thousand. The company's market cap is $79.03 million.
According to TipRanks.com, B.Riley FBR analyst Marc Wiesenberger is a 5-star analyst with an average return of 32.5% and a 53.8% success rate.
MTBC, Inc. is a healthcare information technology company, which engages in the provision of web-based solutions and business services to healthcare providers. It operates through the Healthcare Information Technology (IT) and Practice Management segments. The Healthcare IT segment includes revenue cycle management and other services. The Practice management segment involves in the management of three medical practices. The company was founded by Mahmud Ul Haq on September 28, 2001 and is headquartered in Somerset, NJ.